More Than Half of UK Docs Support Assisted Dying


Assisted dying is not legal in the United Kingdom, but debate over the issue continues, most recently in a series of articles published online February 7 in the BMJ.

The organization that represents physicians — the British Medical Association (BMA) — does not accurately represent their views on the issue, argues Dr Jacky Davis, consultant radiologist at the Whittington Hospital in London, in a personal view article.

The BMA has long been opposedto assisted dying, and its view is often quoted in parliamentary debate as representing that of physicians, she comments.

But a recent opinion poll of physicians (conducted in October 2017 by doctors.net) found that 55% agreed or strongly agreed that assisted dying should be made legal in defined circumstances; 43% disagreed, and 2% had no opinion.

Hence, the BMA should change its policy and adopt a neutral position — “a stance that would allow for constructive engagement while acknowledging the range of views of the membership,” she argues.

Dr Davis, who is also a member of BMA Council, a board member of Dignity in Dying, and chair of Healthcare Professionals for Assisted Dying, argues that the current disconnect between BMA policy and the views of physicians and patients “undermines the BMA’s credibility, and its continuing opposition excludes it from the public debate.”

Assisted dying does not represent a leap into a dangerous unknown. Dr Jacky Davis

“Assisted dying does not represent a leap into a dangerous unknown,” Dr Davis writes. “Other jurisdictions have proved that it is possible to change the law, and doctors have shown that such laws can work hand in hand with excellent palliative care.”

Public Morality Shift?

“It feels as if we are experiencing a rare example of public morality shifting ahead of legislative change,” writes Dr Bobbie Farsides, professor of clinical and biomedical ethics at the University of Sussex, in a commentary.

Prof Farsides acted as adviser to the House of Lords committee that considered the Assisted Dying Bill in 2015. At that time, very strong views were expressed both for and against the legislation, as previously reported by Medscape Medical News.

But the polarization of past parliamentary debates is “no longer reflected in society, given recent opinion polls,” she comments.

She was referring to a poll of the general public conducted in 2015 that found that 82% supported legislation for assisted dying.

“Given this is so, the law may well change soon,” Prof Farsides comments.

She has been involved in the debate about assisted dying for the past 20 years, after she wrote an editorial for the Journal of Medical Ethics (1998;24:149-50). “I argued that it was logically consistent to be a good palliative care doctor and to think that for some patients the best option would be a managed death,” Prof Farsides writes.

“I have never campaigned for or against legal assisted dying,” she states. Instead, she presents evidence from countries where assisted dying is legal and invites colleagues to draw their own conclusions.

“Patients are more aware than ever of what is, and is not, possible for them as they approach the end of their lives, and practitioners need to be prepared and able to respond compassionately,” she comments.

“Surely we have come to understand that there need be no contradiction between being a good palliative care doctor and respecting a patient’s wish to die and their request for assistance,” she concludes.

“Not a Proper Role for Doctors”

Arguing the case against passage of legislation in a “head-to-head” article is Dr Bernard Ribeiro, former president of Royal College of Surgeons and a member of the House of Lords. In 2015, when the Assisted Dying Bill was rejected in the United Kingdom, he argued that “assisting patient suicides was not a proper role for doctors.

“I hold to that view and I make no apology for using the term assisting suicide,” he writes. “In law, supplying terminally ill patients with lethal drugs with which to end their lives constitutes assisting suicide.”

This is “a matter for the courts, not for the consulting room,” he argues.

Dr Ribeiro emphasizes the uneveness of the physician-patient relationship. “The doctor holds most of the cards. We have professional expertise that most patients are in no position to challenge.”

He worries about vulnerable patients “who, not unreasonably, could interpret a doctor’s willingness to process a request for ‘something to end it all’ as meaning that in the doctor’s view, ending their lives is a course of action that would be in their ‘best interest.’ ”

Controversy Subsides After Legislation

“Although plans to adopt assisted dying have caused much controversy, most places have found that once the political decision has been made this tends to subside,” writes journalist Bob Roehr in a feature article in the BMJ.

“The pattern has been repeated many times, beginning 20 years ago in the state of Oregon,” he writes. Since that time, the pattern has been followed in five other states, including the most populous state, California. The pattern has also emerged in Canada.

Roehr highlights a disconnect in the United States between physicians and the American Medical Association (AMA) that is similar to the disconnect between physicians and the BMA in the United Kingdom.

The AMA opposes assisted dying, and the American College of Physicians (ACP) and the American Academy of Family Physicians are opposed to physician-assisted suicide.

Yet in a 2016 Medscape poll, 57% of US physicians showed support for assisted dying, and in a 2017 Medpage poll, 61% of healthcare professionals showed support.

The situation was different in Canada, where medical aid in dying was legalized in 2016, Roehr notes.

“The Canadian Medical Association initially resisted assisted dying. But after that country’s high court ruled it to be a fundamental human right, the association embraced the decision and participated in writing the law, provincial regulations, and training its members to implement that ruling,” he writes.

Stefanie Green, MD, president of the Canadian Association of Medical Assistance in Dying Assessors and Providers (CAMAP), says she is seeing a gradual increase in willingness among physicians to learn and participate in assisted dying when their patients express interest, he adds.

BMJ Calls for a Neutral Position

“The BMJ supports the legalisation of assisted dying,” says Dr Fiona Godlee, the BMJ’s editor in chief, in a statement.

“The great majority of the British public are in favour and there is now good evidence that it works well in other parts of the world, as a continuation of care for patients who request it and are in sound mind. We believe that this should be a decision for Society and Parliament, and that medical organisations should adopt at least a neutral position to allow an open and informed public debate.”

Taking an Emotional Toll

Physicians’ experience of how it feels to be involved in assisted dying is detailed in an essay written by Dr Sabine Netters, now a consultant in medical oncology and palliative care at the Isala Oncology Center, Zwolle, the Netherlands.

She describes her first experience of euthanasia, which occurred 10 years ago, when she was a medical trainee. The patient had metastatic cancer with paraplegia caused by spinal metastasis, which left him “paralysed from the waist down, unable to control his bowels, his skeleton ridden with cancers.”

“He makes me see that even when therapy fails, the doctor’s role is far from over,” Dr Netters writes. “Instead it adjusts, because the goal has changed from living longer to dying better.

“But textbooks offer no advice, and years of training have left me totally unprepared for this,” she adds.

She writes that after the patient has died from a lethal injection, surrounded by his family, “I’ve just helped kill someone, but I don’t see it in a negative way. It was beautiful.

“As a doctor I will do anything to save a life, and this evening that meant giving someone a dignified death,” she adds.

She also details the emotional toll that the process takes on the physicians involved.

“I hoped euthanasia would become less of an emotional burden to me as my experience grew,” Dr Netters writes, noting that she has helped five patients to die over the past 10 years.

“But it didn’t, and now I know it never will,” she writes.

“The general population, politicians, and legislators — perhaps even some doctors who have not been involved in the procedure — seem to think that assisted dying or euthanasia is just another medical intervention,” she comments. “It is not.”

GSK to stop doctor incentive schemes


GSK to stop paying doctors to make speeches

Editor of the British Medical Journal Fiona Godlee: “Doctors need independent, unbiased information about drugs”

GlaxoSmithKline (GSK) is making major changes to its incentive schemes following a damaging corruption scandal in China.

The pharmaceuticals firm will stop paying doctors to promote its products through speaking engagements.

Members of its sales force will also no longer have individual sales targets.

Earlier this year, Chinese police said GSK had transferred 3bn yuan ($489m; £321m) to travel agencies and consultancies to help bribe doctors.

But the company says the latest measures are not related to that continuing investigation. Instead, it says, they are part of a wider effort to improve transparency.

‘Greater clarity’

“Start Quote

There is a long way to go if we are truly to extricate medicine from commercial influence”

Fiona Godlee Editor, British Medical Journal

In a statement, Sir Andrew Witty, chief executive of GSK, said: “Today we are outlining a further set of measures to modernise our relationship with healthcare professionals.

“These are designed to bring greater clarity and confidence that whenever we talk to a doctor, nurse or other prescriber, it is patients’ interests that always come first.”

As well as stopping payments to doctors for making speeches, GSK is also ending payments to healthcare professionals for attending medical conferences.

A spokesperson told the BBC that there were “perceived conflicts of interest with that way of working”.

GSK plans a new system under which independent organisations, such as universities, can approach GSK for a grant if they want a particular doctor to attend a medical conference.

Doctors ‘satisfied’

In a statement, Dr Vivienne Nathanson, head of science and ethics at the British Medical Association (BMA), which represents doctors, said: “Whilst we agree that GSK should not directly sponsor doctors going to meetings, we are satisfied that they will continue to financially support education.

“It is pleasing to see a large pharmaceutical company like GlaxoSmithKline recognise that it can reduce the possibility of undue influence by rewarding employees for providing high-quality information and education for doctors, rather than for their sales figures.”

GSK says sales representatives will be rewarded for “technical knowledge” and the “quality of the service they deliver to support improved patient care”. Their compensation will also be linked to the overall performance of GSK.

Salespeople in the US have already been working under those conditions since 2011.

A spokesperson from GSK said: “It was always our intent to roll it out globally.”

Paying doctors to make speeches and attend conferences is common in the pharmaceuticals industry, but there is growing demand for reform.

“Where GSK leads we must hope that other companies will follow,” Fiona Godlee, editor of the British Medical Journal and a campaigner against industry influence in medicine, told the Reuters news agency.

“But there is a long way to go if we are truly to extricate medicine from commercial influence. Doctors and their societies have been too ready to compromise themselves.”

‘Non-trivial’

Ben Goldacre, author of the book Bad Pharma, is concerned about the quality of advice received by doctors.

He told BBC Radio 4: “Doctors get a lot of their education about which treatment works best from the pharmaceutical industry itself – from doctors who have been paid to give lectures about which drug is best.

“This free education has been shown to be be biased in research and it’s non-trivial.”

Andrew Powrie-Smith, director at the Association of the British Pharmaceutical Industry, told BBC Radio 4: “A number of companies I think are looking at this area and different models of education are emerging.”

He stressed that by 2016 companies would have to disclose how much they pay individual doctors.

EU-approved ‘safe’ air pollution levels causing early deaths.


Published time: December 09, 2013 14:08
Edited time: December 10, 2013 08:37

General view of the Origny sugar factory in Sainte-Benoite near Saint-Quentin. (AFP Photo / Philippe Huguen)General view of the Origny sugar factory in Sainte-Benoite near Saint-Quentin. (AFP Photo / Philippe Huguen)

Air pollution in the European Union is causing premature deaths even when levels meet quality guidelines, a report has shown. Even in areas where pollution was much lower than the limit, scientists found there is a higher-than-normal risk of death.

The study, published the British Medical Association’s journal The Lancet, found that Europeans who have had prolonged exposure to pollution from industrial activities or road traffic have a higher chance of premature death. The increased risk to a person’s health is linked to tiny particles of soot and dust than can get lodged in the lungs and cause respiratory illnesses.

The study, carried out by Utrecht University in the Netherlands, found the particles measure 2.5 microns or 2.5 millionth of a meter. Exposure for “up to a few months” to particles of 2.5 microns can increase the risk of premature death.

“Although this does not seem to be much, you have to keep in mind that everybody is exposed to some level of air pollution and that it is not a voluntary exposure, in contrast to, for example, smoking,” scientist Rob Beelen, who led the study, told AFP.

The findings of the study echo the results of similar investigations carried out in North America and China.

“Our findings support health impact assessments of fine particles in Europe which were previously based almost entirely on North American studies,” Beelen said.

As part of the study the researchers drew on 22 previously published studies that documented the health of 367,000 people in 13 countries in Western Europe over 14 years. Beelen and his team then traveled to the areas where the participants lived and took traffic pollution readings that they used to calculate how much pollution local residents were exposed to.

 

AFP Photo / Frederick FlorinDuring the investigation, 29,000 of the 367,000 participants recruited in 1990 died. In order to increase accuracy, investigations also took into account such factors as physical exercise, body mass, education and smoking habits. 

European Union guidelines set the maximum exposure to particles of 25 micrograms per cubic meter. Beelen says the results of this study are evidence the EU needs to reset its safety limits to 10 micrograms per cubic meter.

“Despite major improvements in air quality in the past 50 years, the data from Beelen and his colleagues’ report draw attention to the continuing effects of air pollution on health,” Jeremy Langrish and Nicholas Mills, of the University of Edinburgh, told the Medical Press.

In China a red alert was issued for poor air quality was issued Thursday after pollution reached hazardous levels. The coastal city of Qingdao recorded PM2.5 Air Quality Index levels of over 300, while Nanjing saw a reading of 354 on Wednesday, according to local news portal news.longhoo.net.

In light of the dangerous levels of pollution the Chinese government is considering the practice of ‘cloud seeding’ to clear toxic fog in the country. According to a document released by the China Meteorological Administration, from 2015 local meteorological authorities will be permitted to use cloud seeding to disperse pollution.

The World Health Organization has classified outdoor pollution as one of the principal causes of cancer and estimates around 3.2 million people die every year globally as a result of prolonged exposure.

E-cigarettes ‘could save millions’


Scientists say that if all smokers in the world switched from cigarettes to electronic cigarettes, it could save millions of lives.

Woman smoking an electronic cigarette

In the UK there are currently about 100,000 deaths per year attributable to smoking, worldwide it is estimated to be more than five million.

Now researchers are hopeful that an increasing use of e-cigarettes could prevent some of these deaths.

But some groups warn that e-cigarettes could normalise smoking.

An estimated 700,000 users smoke e-cigarettes in the UK, according to Action on Smoking and Health. Some users combine “vaping”, as it is often called, with traditional cigarettes while others substitute it for smoking completely.

E-cigarettes have also recently be found to be just as effective as nicotine patches in helping smokers quit.

Future hope

Rather than inhaling the toxic substances found in tobacco, e-cigarette users inhale vaporised liquid nicotine.

Robert West, professor of health psychology at University College London, told delegates at the 2013 E-Cigarette Summit at London’s Royal Society that “literally millions of lives” could be saved.

“Start Quote

Every adolescent tries something new, many try smoking. I would prefer they try e-cigarettes to regular cigarettes”

Dr Jacques Le Houezec Tobacco and nicotine researcher

“The big question, and why we’re here, is whether that goal can be realised and how best to do it… and what kind of cultural, regulatory environment can be put in place to make sure that’s achieved.

“I think it can be achieved but that’s a hope, a promise, not a reality,” he said.

A revolution

This view was echoed by Dr Jacques Le Houezec, a private consultant who has been researching the effects of nicotine and tobacco.

He said that because the harmful effects of its main comparator, tobacco, e-cigarette use should not be over-regulated.

“We’ve been in the field for very long, this for us is a revolution.

E-cigarettes
There is concern over the lack of regulation of e-cigarettes

“Every adolescent tries something new, many try smoking. I would prefer they try e-cigarettes to regular cigarettes.” Dr Le Houezec added.

Many are now calling for the industry to be regulated. An EU proposal to regulate e-cigarettes as a medicine was recently rejected, but in the UK e-cigarettes will be licensed as a medicine from 2016.

Konstantinos Farsalinos, from the University Hospital Gathuisberg, Belgium, said it was important for light regulation to be put in place “as soon as possible”.

“Companies are all hiding behind the lack of regulation and are not performing any tests on their products, this is a big problem.”

Prof Farsalinos studies the health impacts of e-cigarette vapour. Despite the lack of regulation, he remained positive about the health risks associated with inhaling it.

Healthy rats

E-cigarettes are still relatively new, so there is little in the way of long-term studies looking at their overall health impacts.

In order to have valid clinical data, a large group of e-cigarette users would need to be followed for many years.

Seeing as many users aim to stop smoking, following a large group of e-smokers for a long period could be difficult.

But in rats at least, a study showed that after they inhaled nicotine for two years, there were no harmful effects. This was found in a 1996 study before e-cigarettes were on the market, a study Dr Le Houezec said was reassuring.

Concern about the increase in e-cigarette use remains.

The World Health Organization advised that consumers should not use e-cigarettes until they are deemed safe. They said the potential risks “remain undetermined” and that the contents of the vapour emissions had not been thoroughly studied

Woman smoking electronic cigarette
E-cigarettes still divide opinion

The British Medical Association has called for a ban on public vaping in the same way that public smoking was banned.

They stated that a strong regulatory framework was needed to “restrict their marketing, sale and promotion so that it is only targeted at smokers as a way of cutting down and quitting, and does not appeal to non-smokers, in particular children and young people”.

Ram Moorthy, from the British Medical Association, said that their use normalises smoking behaviour.

“We don’t want that behaviour to be considered normal again and that e-cigarettes are used as an alternative for the areas that people cannot smoke,” he told BBC News.

But Lynne Dawkins, from the University of East London, said that while light-touch regulation was important, it must be treated with caution.

She said that e-cigarettes presented a “viable safer alternative” to offer to smokers.

“We don’t want to spoil this great opportunity we have for overseeing this unprecedented growth and evolving technology that has not been seen before, We have to be careful not to stump that.”

E-cigarettes face new restrictions.


_68124479_equpwh3p

Electronic cigarettes will be licensed as a medicine in the UK from 2016, under new regulations.

The UK currently has few restrictions on the use of e-cigarettes, despite moves in some countries to ban them.

The Medicines and Healthcare Products Regulatory Agency says it will regulate e-cigarettes as medicines when new European tobacco laws come into force.

Sales of tobacco-free cigarettes have boomed worldwide since bans on smoking in public places were introduced.

Campaigners say the growing popularity of e-cigarettes could undermine years of anti-smoking efforts, with particular concerns about promotion to children and non-smokers.

Research suggests around 1.3m smokers and ex-smokers in the UK use the products, which are designed to replicate smoking behaviour without the use of tobacco.

They turn nicotine and other chemicals into a vapour that is inhaled.

 “Start Quote

Regulation can ensure that adult smokers can continue to be able to buy e-cigarettes as easily as tobacco, but promotion to children or non-smokers will be prohibited”

Deborah ArnottASH

Jeremy Mean of The Medicines and Healthcare Products Regulatory Agency (MHRA) said the government had concluded that e-cigarettes currently on the market do not meet appropriate standards of safety, quality and efficacy.

He said “levels of contamination” had been found in the products and some were poorly manufactured.

Not recommended

There will be no compulsory licensing of the products until 2016 but until then they are not recommended for use, he said.

“We can’t recommend these products because their safety and quality is not assured, and so we will recommend that people don’t use them,” he told a news conference.

The MHRA had decided not to ban the products entirely but to work towards a position where they are licensed, he added.

“Smoking is the riskiest thing you can do – we want to enable people to cut down and quit – we don’t think a ban is a proportionate action.”

The health campaign body, Action on Smoking and Health (ASH), said the action will ensure promotion to children or non-smokers is prohibited.

E-cigarettes: pros and cons

  • The British Medical Association says health professionals should encourage their patients to use a regulated and licensed nicotine replacement therapy (such as patches or gum) to help quit smoking
  • It says health professional may advise patients that while e-cigarettes are unregulated and their safety cannot be assured, they are likely to be a lower risk option than continuing to smoke

Deborah Arnott, chief executive of ASH, said: “MHRA regulation can ensure that adult smokers can continue to be able to buy e-cigarettes as easily as tobacco, but promotion to children or non-smokers will be prohibited.”

Chief Medical Officer Professor Dame Sally Davies said with more people using e-cigarettes it was only right that the products were properly regulated to be safe and work effectively.

“Smokers are harmed by the deadly tar and toxins in tobacco smoke, not the nicotine,” she said.

“While it’s best to quit completely, I realise that not every smoker can and it is much better to get nicotine from safer sources such as nicotine replacement therapy.”

Manufacturers of e-cigarettes say the products have the potential to save lives and should not be restricted.

Adrian Everrett, chief executive officer of E-Lites, told the BBC: “So far not one person globally has been killed by an electronic cigarette and yet every 5 minutes in this country alone someone dies from tobacco use.

“To remove or restrict the use or availability of the electronic cigarette from this market would be a significant health loss.”

Once licensed, e-cigarettes are expected to remain on sale over-the-counter in the UK.

In some countries, such as New Zealand, e-cigarettes are regulated as medicines and can be purchased only in pharmacies.

In other countries, including Denmark, Canada and Australia, they are subject to restrictions on sale, import and marketing. Complete bans are in place in Brazil, Norway and Singapore.

Dr Mike Knapton, Associate Medical Director at the British Heart Foundation, said more research was needed into the potential health implications of long-term nicotine use.

“The MHRA has rightly addressed the worrying dearth of regulation around nicotine-containing products and electronic cigarettes – an important step to ensuring their safety,” he said.

“Marketing of these products must now be closely monitored to ensure non-smokers and children don’t end up using them.”

Source: BBC

 

 

Each GP saves 4.7 lives a year, say researchers.


save life

Each GP saves nearly five lives a year, shows the first study to estimate the impact of disease prevention by practices.

Researchers estimated the public health impact (PHI) score for all practices in England and found 139,100 lives were saved nationally as a direct result of disease preventation activities in 2009/2010.

This equated to an average, per GP, of 4.71 lives saved a year.

The research, to published be in the British Journal of General Practice next month, is the first to quantify the impact of GPs on lives saved, with the PHI score calculated based on 20 QOF indicators, including those for flu vaccination, smoking cessation advice, and HbA1c control.

QOF data was taken from 8,136 general practices in England for the study, 97.97% of all practices.

They found the mean estimated PHI score was 258.9 lives saved per 100,000 registered patients, per year. This represented 75.7% of the maximum potential PHI score of 340.9.

The researchers said they hoped the PHI score would help CCGs to assess the impact of practices more accurately and lead to better public health outcomes.

Study leader Dr Mark Ashworth, a GP in south-east London and clinical senior lecturer at King’s College London, said that the study gave GPs a real measure of how much good they are doing in the community.

He said: ‘What this is doing for the first time is giving GPs a feel that, actually, all that disease prevention work they do translates into something really tangible.

“This figure is a way of looking at how well you are doing which is not so much using the management agenda, which is so often what’s being applied to general practice. It is using something that means much more to GPs, and much more to patients. It translates into a figure for lives saved.’

He added that the score was not necessarily related to high overall QOF scores: ‘You’ve got other sets of practices that don’t do very well at QOF – so aren’t said to be doing very well in terms of care performance – and yet their PHI score is very high.

‘It gives you some sense that QOF isn’t fully rewarding the practices that have necessarily performed best in terms of saving lives out in their community.’

Source: http://www.pulsetoday.co.uk